Nintedanib plus mFOLFOX6 as second-line treatment of...

  • Main
  • 2020 / 09
  • Nintedanib plus mFOLFOX6 as second-line treatment of...

Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: the randomized, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)

Ettrich, Thomas J., Perkhofer, Lukas, Decker, Thomas, Hofheinz, Ralf-Dieter, Heinemann, Volker, Hoffmann, Thomas, Hebart, Holger F., Herrmann, Thomas, Hannig, Carla V., Büchner-Steudel, Petra, Güthl
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.33296
Date:
September, 2020
File:
PDF, 1.24 MB
2020
Conversion to is in progress
Conversion to is failed